Science SignalingPhysiologyPeer-reviewed journal article
Dual Translational Control in Cardiomyocytes by Heterogeneous mTORC1 and Hypertrophic ERK Activation
Keita UchidaiD, Emily Anne ScarboroughiD, Elizabeth PruzinskyiD, Kathlyene R. StoneiD, Hali HartmaniD, Daniel P. KellyiD, Jonathan J. EdwardsiD, Izhak KehatiD, Benjamin L. ProsseriD
Abstract
BackgroundCardiac hypertrophy allows post-mitotic cardiomyocytes to meet increased hemodynamic demands but can predispose the heart to adverse clinical outcomes. Despite its central role in cardiac adaptation, the translational control mechanisms that drive cardiac hypertrophy are poorly understood. In this study, we elucidate the relative contributions of the various translational control mechanisms operant during homeostasis and hypertrophic growth. MethodsA combination of immunofluorescence and single myocyte protein synthesis assays were used to dissect the single-cardiomyocyte mechanisms of translational control under basal and hypertrophic conditions in isolated adult rat cardiomyocytes. Translational control mechanism were examined in a mouse model of acute hypertrophic phenylephrine (PE) stimulation prior to overt cardiac growth. ResultsWe observed strikingly heterogeneous activity of mTORC1, the master regulator of translation, across cardiomyocytes both in situ and ex vivo. Heterogeneous mTORC1 activity drove heterogeneous protein synthesis, with translation primarily controlled via canonical mTORC1-dependent 4EBP1 phosphorylation at Thr36/Thr45/Thr69 under baseline conditions. Hypertrophic PE stimulation recruited more cardiomyocytes into a high mTORC1 activity state. PE induced a switch in 4EBP1 phosphorylation by increasing mTORC1-dependent phosphorylation at Thr36/Thr45, but not Thr69. Further, PE induced a novel mTORC1-independent, but MEK-ERK-dependent, pathway driving 4EBP1 phosphorylation at Ser64 in both isolated cardiomyocytes and in vivo. Ribosome biogenesis was also observed within hours upon hypertrophic stimulation, while the mTORC1-S6K-eEF2K-eEF2 pathway was not found to be a major driver of protein translation. ConclusionsProtein synthesis is heterogeneous across cardiomyocytes driven by heterogeneous mTORC1 activity. MEK-ERK signaling directly controls 4EBP1 phosphorylation to augment translation during cardiac hypertrophy and challenges the canonical model of translation initiation. Key pointsO_LImTORC1 activity is low and heterogeneous across cardiomyocytes at baseline. C_LIO_LIHeterogeneous mTORC1 activity drives variable 4EBP1 phosphorylation at Thr36/Thr45/Thr69, resulting in heterogeneous protein translation. C_LIO_LIPhenylephrine stimulation recruits more cardiomyocytes into a high mTORC1 activity state to augment protein synthesis through 4EBP1 phosphorylation at Thr36/Thr45, but not Thr69. C_LIO_LIPhenylephrine stimulation boosts protein translation through mTORC1-independent but ERK-dependent phosphorylation of 4EBP1 at Ser64. C_LIO_LImTORC1-S6K-eEF2K-eEF2 pathway is not a major driver of global protein translation. C_LIO_LIRibosome biogenesis is observed within hours after hypertrophic stimulation. C_LIO_LIThe data demonstrates a dual input model of mTORC1 and ERK dependent phosphorylation of 4EBP1 to regulate protein translation in cardiomyocytes. C_LI
- Citations
- 6
- FWCI
- 10.22
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single molecule imaging reveals extracellular signal-regulated kinases dependent signal responsive spatial regulation of translation in cardiomyocytes
Itai Erlich, Guy Douvdevany, … Izhak Kehat·bioRxiv·May 5, 2025
- Polycystin-1 C-Terminus Regulates Protein Synthesis-Related Pathways in Cardiomyocytes
Matthew J. Fiedler, Alejandra Vásquez‐Limeta, … Francisco J Altamirano·bioRxiv·Mar 24, 2026
- Phosphoproteomics of Hypertrophic Cardiomyopathy Patient Myocardium and Novel hiPSC-CM Model Reveal Protein Kinase A as a Modulator of Microtubule Repolymerization
Sıla Algül, Inez Duursma, … Jolanda van der Velden·bioRxiv·Feb 20, 2026
- Cardiac Specific Overexpression of Transcription Factor EB (TFEB) in Normal Hearts Induces Pathologic Cardiac Hypertrophy and Lethal Cardiomyopathy
H. C. Kenny, E. T. Weatherford, … E. D. Abel·bioRxiv·Feb 16, 2021
- Nutrient-dependent pathology in mitochondrial hypertrophic cardiomyopathy model
Swagat Pradhan, Nahid Akthar Khan, … Anu Suomalainen·bioRxiv·Sep 24, 2025
- Differential activation of P-TEFb complexes in the development of cardiomyocyte hypertrophy following activation of distinct GPCRs
Ryan Martin, Ya‐Lin Sun, … Jason C. Tanny·Molecular and Cellular BiologyPeer-reviewed·Apr 22, 2020